Onderneming Poseida Therapeutics, Inc.
Aandelen
PSTX
US73730P1084
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,18 USD | +3,25% | +4,61% | -5,36% |
Vakgebied
Aantal werknemers: 330
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cell and Gene Therapies
100,0
%
| 130 | 100,0 % | 65 | 100,0 % | -50,42% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 130 | 100,0 % | 65 | 100,0 % | -50,42% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kristin Yarema
CEO | Chief Executive Officer | 53 | 01-04-23 |
Johanna Mylet
DFI | Director of Finance/CFO | 37 | 01-06-15 |
Mark Gergen
CHM | Chairman | 61 | 01-02-18 |
Loren Wagner
COO | Chief Operating Officer | - | 01-03-21 |
Chief Tech/Sci/R&D Officer | - | - | |
Kristin Martin
ADM | Chief Administrative Officer | 49 | 01-01-19 |
Harry Leonhardt
CMP | Compliance Officer | 67 | 16-07-20 |
Sarah Thailing
IRO | Public Communications Contact | - | 01-11-20 |
Brent Warner
PRN | Corporate Officer/Principal | 40 | 21-02-22 |
Lisa Portale
LAW | General Counsel | - | 01-01-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Marcea Lloyd
BRD | Director/Board Member | 75 | 01-01-19 |
Cynthia Collins
BRD | Director/Board Member | 65 | 23-07-21 |
Mark Gergen
CHM | Chairman | 61 | 01-02-18 |
John Schmid
BRD | Director/Board Member | 60 | 19-07-18 |
Charles Baum
BRD | Director/Board Member | 65 | 16-05-22 |
Rafael Amado
BRD | Director/Board Member | 60 | 13-04-23 |
Kristin Yarema
CEO | Chief Executive Officer | 53 | 01-04-23 |
Luke Corning
BRD | Director/Board Member | 41 | 16-12-20 |
Bedrijfsgegevens
Poseida Therapeutics, Inc.
9390 Towne Centre Drive Suite 200
92121, San Diego
+858 779 3100
http://www.poseida.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,36% | 297 mln. | |
+2,73% | 108 mld. | |
+9,61% | 104 mld. | |
+6,58% | 23,66 mld. | |
-12,59% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,36% | 18,2 mld. | |
-13,31% | 16,19 mld. | |
+4,68% | 13,72 mld. | |
+34,15% | 12,22 mld. |
- Beurs
- Aandelen
- Aandeel Poseida Therapeutics, Inc. - Nasdaq
- Onderneming Poseida Therapeutics, Inc.